T 1540/21 (Infant formulas containing DHA and lutein II/ABBOTT) of 23.02.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T154021.20230223
- Date of decision
- 23 February 2023
- Case number
- T 1540/21
- Petition for review of
- -
- Application number
- 10189228.9
- IPC class
- A23L 33/12A23L 33/00A23L 33/105
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Infant formulas containing docosahexaenoic acid and lutein
- Applicant name
- ABBOTT LABORATORIES
- Opponent name
- Société des Produits Nestlé S.A.
- Board
- 3.3.09
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Novelty - (no)
Novelty - availability to the public
Novelty - enabling disclosure
Amendment to case - amendment admitted (yes)
Amendment after summons - exceptional circumstances (yes) - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.